According to Celon Pharma's latest financial reports the company's current EPS (TTM) is -โน9.23. In 2023 the company made an earnings per share (EPS) of -โน11.99 an increase over its 2022 EPS that were of -โน15.10.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -โน8.99 | -24.99% |
2023 | -โน11.99 | -20.64% |
2022 | -โน15.10 | 186.32% |
2021 | -โน5.27 | 1047.74% |
2020 | -โน0.46 | -107.56% |
2019 | โน6.08 | -59.53% |
2018 | โน15.03 | 7.36% |
2017 | โน14.00 | -18.58% |
2016 | โน17.19 | -5.31% |
2015 | โน18.16 |